NCT02762955View on ClinicalTrials.gov

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

October 15, 2018

Conditions
Psoriasis
Interventions
BIOLOGICAL

BCD-057

BCD-057 is biosimilar of adalimumab (produced by BIOCAD).

BIOLOGICAL

Humira®

Humira is the original adalimumab (produced by F. Hoffman-La Roche)

Trial Locations (1)

198515

BIOCAD, Saint Petersburg

Sponsors

Lead Sponsor

Biocad
All Listed Sponsors
lead

Biocad

INDUSTRY

NCT02762955 - Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis | Biotech Hunter | Biotech Hunter